DISCONTINUED OPERATIONS - NET EARNINGS FROM DISCONTINUED OPERATIONS (DETAILS) (USD $) In Millions, unless otherwise specified	3 Months Ended									12 Months Ended
	Jun. 30, 2012		Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2010
Net sales										$ 1,440	$ 1,455	$ 2,123
Earnings from discontinued operations										266	322	595
Income tax expense										(96)	(93)	(185)
Gain on sale of discontinued operation										1,899	0	2,632
Income tax benefit (expense) on sale										(482)	0	(1,047)
Net earnings from discontinued operations	1,454	[1]	34	41	58	71	47	56	55	1,587	229	1,995
Snacks Business
Net sales										1,440	1,455	1,372
Earnings from discontinued operations										266	322	289
Income tax expense										(96)	(93)	(84)
Gain on sale of discontinued operation										1,899	0	0
Income tax benefit (expense) on sale										(482)	0	0
Net earnings from discontinued operations										1,587	229	205
Pharmaceuticals Business
Net sales										0	0	751
Earnings from discontinued operations										0	0	306
Income tax expense										0	0	(101)
Gain on sale of discontinued operation										0	0	2,632
Income tax benefit (expense) on sale										0	0	(1,047)
Net earnings from discontinued operations										$ 0	$ 0	$ 1,790

[1] The Company divested of its snacks business in May 2012. See Note 12 to the Consolidated Financial Statements for details of the transaction.